These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2440232)

  • 21. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.
    Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M
    Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunohistochemistry of the prostate and prostate carcinomas].
    Wernert N
    Veroff Pathol; 1991; 135():1-163. PubMed ID: 2038892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Keratin 19 in the adult human prostate: tissue and cell culture studies.
    Peehl DM; Sellers RG; McNeal JE
    Cell Tissue Res; 1996 Jul; 285(1):171-6. PubMed ID: 8766871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
    Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
    Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma.
    Hedrick L; Epstein JI
    Am J Surg Pathol; 1989 May; 13(5):389-96. PubMed ID: 2469333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The application of high molecular weight cytokeratin in differential diagnosis of prostate adenocarcinoma].
    Kong X; Deng F; Wang J
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):199-201. PubMed ID: 9275650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
    Garcia FU; Haber MM; Chen X
    Prostate; 2007 Nov; 67(15):1686-92. PubMed ID: 17879949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate basal cell lesions can be negative for basal cell keratins: a diagnostic pitfall.
    Zhou M; Magi-Galluzzi C; Epstein JI
    Anal Quant Cytol Histol; 2006 Jun; 28(3):125-9. PubMed ID: 16786721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Zn-alpha 2-glycoprotein and PSP-94 in prostatic adenocarcinoma. An immunohistochemical study of 88 cases.
    Gagnon S; Têtu B; Dubé JY; Tremblay RR
    Am J Pathol; 1990 May; 136(5):1147-52. PubMed ID: 2349965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue.
    Dairkee SH; Puett L; Hackett AJ
    J Natl Cancer Inst; 1988 Jul; 80(9):691-5. PubMed ID: 2453676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epitheliosis of the breast. An immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast.
    Raju U; Crissman JD; Zarbo RJ; Gottlieb C
    Am J Surg Pathol; 1990 Oct; 14(10):939-47. PubMed ID: 1698341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
    Parsons JK; Gage WR; Nelson WG; De Marzo AM
    Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Florid basal cell hyperplasia of the prostate: a histological, ultrastructural, and immunohistochemical analysis.
    Yang XJ; Tretiakova MS; Sengupta E; Gong C; Jiang Z
    Hum Pathol; 2003 May; 34(5):462-70. PubMed ID: 12792920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate.
    Xue Y; Verhofstad A; Lange W; Smedts F; Debruyne F; de la Rosette J; Schalken J
    Am J Pathol; 1997 Dec; 151(6):1759-65. PubMed ID: 9403726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates.
    Brawer MK; Nagle RB; Pitts W; Freiha F; Gamble SL
    Cancer; 1989 Feb; 63(3):454-60. PubMed ID: 2463873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphologic assay of steroid hormone receptors in human neoplasia.
    Pertschuk LP; Tobin EH; Brigati DJ; Gaetjens E
    Pathol Annu; 1980; 15(Pt 2):143-80. PubMed ID: 6161331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.